Orotidine 5′-monophosphate (trisodium)
Orotidine 5'-monophosphate trisodium is a pyrimidine nucleotide. Orotidine 5'-monophosphate trisodium is synthesized via the de novo synthesis pathway for DNA synthesis in a large number of microorganisms including M. tuberculosis, S. cerevisiae, S. typhimurium and P. falciparum to name a few. The synthesis of orotidine 5'-monophosphate trisodium uses phosphoribosyl pyrophosphate (PRPP) and orotic acid (OA) as the substrates catalyzed by orotate phosphoribosyltransferase (OPRT) [1].
Product Specifications
CAS Number
68244-58-6
Product Name Alternative
Orotidine monophosphate (trisodium) ; Orotidylic acid (trisodium)
UNSPSC
12352005
Target
DNA/RNA Synthesis; Endogenous Metabolite
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/orotidine-5-monophosphate-trisodium.html
Purity
99.86
Solubility
H2O : 50 mg/mL (ultrasonic; warming)
Smiles
O=C(C(N([C@H]1[C@@H]([C@@H]([C@@H](COP(O[Na])(O[Na])=O)O1)O)O)C2=O)=CC(N2)=O)O[Na]
Molecular Formula
C10H10N2Na3O11P
Molecular Weight
434.14
References & Citations
[1]Subrahmanyeswara Rao NN, et al. QM/MM reveals the sequence of substrate binding during OPRT action. Comput Biol Chem. 2018 Jun;74:31-38.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL
CD50 (ICAM-3) (101-1D2), CF405S conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF568 conjugate, 0.1mg/mL
Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (rKRT19/799), CF568 conjugate, 0.1mg/mL
